Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alosetron PRN vs Fixed Dosing in Severe IBS-D
NCT00067457Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2003
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Alosetron in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by GSK. Started Jun 2003; status: completed.
02
Drugs
Alosetron
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT00067457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067457.